- Immunogenicity of an mRNA-based COVID-19 vaccine among adolescents with obesity or liver transplants
-
Tubjaroen 1 C, Prachuapthunyachart S, Potjalongsilp N, Sodsai P, Jaruampornpan P, Chongsrisawat V
- KMID: 2535456
- Korean J Transplant.
- 2022 Nov;36(Supple 1):S239.
- doi: 10.4285/ATW2022.F-3788
Background: The mRNA-based SARS-CoV-2 vaccine (BNT162b2) is initially used in Thailand as a voluntary policy for children 12–18 years of age. There is limited data regarding the immunogenicity of this... -
- CITED
-
- Close
- SHARE
-
- Close
